Navigation Links
BIO 2010: German Molecular Diagnostics Segment Posting Double-Digit Growth
Date:5/3/2010

BERLIN and CHICAGO, May 3, 2010 /PRNewswire/ -- Molecular diagnostics has quickly become one of the most important biotechnology segments in Germany. With an estimated 10 percent share of the EUR 2 billion German diagnostics market, the segment enjoys a compound annual growth rate of around 12 percent. This growth is driven by industry trends toward personalized medicine that are correspondingly increasing the market for molecular diagnostics. Germany Trade & Invest will have representatives at this year's BIO International Convention in Chicago from May 3 - 6, 2010 to share the latest business opportunities in Germany's biotechnology industry.

There are more companies operating in the biotech and biomedical sectors in Germany than in any other country in Europe. Revenue in this industry has grown over 40 percent between 2005 and 2009 and promises to expand in the coming years. Dedicated biotechnology companies annually invest nearly EUR 1 billion in research and development, securing the industry's innovation potential for the coming years.

The integration of biotechnology clusters further increases the country's attractiveness as a business location. Research institutes and companies large and small can utilize the cluster structure to share ideas, innovate with partners and quickly bring new products to market.

Giving a further boost to Germany's reputation as a high-tech business location, top executives in American companies recently selected Germany as the number one location in Europe. In a survey conducted by the American Chamber of Commerce in Germany (AmCham Germany), they cited Germany's handling of the economic crisis and stable domestic demand as crucial factors. 80 percent of those surveyed even named Germany as their future focal point for investments in Europe.

Germany Trade & Invest will be showcasing the latest developments in Germany's biotechnology industry at Booth 4722 at this year's BIO International Convention. In addition, the organization will be hosting a session on opportunities in Germany under the moniker "Beyond Classical Diagnostics: Breakthroughs in Molecular Diagnostics and Biomarkers from Germany." Speakers will include Michael Lutz, CEO of Life Codexx, a DNA sequencing company that develops clinically validated next generation molecular diagnostics, as well as Hajo Schiewe, Ph.D., Manager Business Development for Metanomics Health, a metabolite profiling company in the area of plant biotechnology. Both will speak about opportunities in their segments in Germany.

Germany Trade & Invest is the foreign trade and inward investment promotion agency of the Federal Republic of Germany. The organization advises foreign companies looking to expand their business activities to the German market. It provides information on foreign trade to German companies that seek to enter foreign markets.

    Germany Trade & Invest
    Eva Henkel
    Email: eva.henkel@gtai.com
    T: +49(0)30-200099-173
    F: +49(0)30-200099-111



'/>"/>
SOURCE Germany Trade and Invest
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Announcing Sustainability in Packaging 2010: Strategies to make sustainability sustainable
2. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
3. Arpida Presents Data on Iclaprim at Scientific Congress in Germany
4. Germany Hosts World Leading Medical Industry Fair
5. A New Era in Cell Biology: German Company Develops Groundbreaking Alternative to Stem Cell Therapy
6. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in Germany
7. World Congress on Industrial Biotechnology: Germany Home to Top Biotech Research and Investment
8. Pharmaxis Aridol Authorised for Sale in Germany
9. BIO 2008: Germany on Cutting Edge in Biomanufacturing
10. Stallergenes : Sublingual Desensitisation Tablets Oralair Grasses Approved in Germany
11. CPA Acquires Renowned German Patent Research Specialist, SVPG
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2016)... ... ... Ryan Benton was diagnosed with Duchenne Muscular Dystrophy (DMD) at the age ... DMD is a relatively common progressive genetic disorder, which causes aggressive deterioration of the ... He met with the founder of the Stem Cell Institute in Panama ...
(Date:5/17/2016)... , ... May 17, 2016 , ... ... and BioSmartSA, a healthcare consultancy based in Saudi Arabia, have formed a partnership ... to healthcare providers in the Kingdom of Saudi Arabia (KSA). , The ...
(Date:5/17/2016)... Switzerland , May 17, 2016 ... company located in Basel, Switzerland ... investigational oral inhibitor of P38 mitogen-activated protein kinase. ... , Strekin will build the necessary ... in indications in which MAP Kinases play fundamental ...
(Date:5/17/2016)... ... ... HOLLOWAY AMERICA, a stainless steel pressure vessel and tank manufacturing company, announced ... 19 in St. Louis, Missouri. The event will be held at the Hilton at ... during the early afternoon of the event, where the company’s representatives will be available ...
Breaking Biology Technology:
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):